O rastreio nacional neonatal da drepanocitose e a comunicação do estado de portador
DOI:
https://doi.org/10.32385/rpmgf.v39i1.13435Keywords:
Drepanocitose, Heterozigoto HbS, Portador, Rastreio neonatal, ComunicaçãoAbstract
Neste momento, Portugal está a implementar um projeto piloto para rastreio de casos de drepanocitose no âmbito do Programa Nacional de Rastreio Neonatal. Este projeto iniciou-se na região de Lisboa e Vale do Tejo onde reside, comparativamente com as outras regiões nacionais, uma maior proporção da população africana. Contudo, antecipando a expansão deste rastreio ao restante do território nacional, deparamo-nos com a seguinte questão: como comunicar os resultados de rastreios positivos para heterozigotos HbS?
Downloads
References
Lobitz S, Kunz JB, Cario H, Hakimeh D, Jarisch A, Kulozik AE, et al. Introduction of universal newborn screening for sickle cell disease in Germany: a brief narrative review. Int J Neonatal Screen. 2021;7(1):7.
Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Johansson CB, et al. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. Br J Haematol. 2018;183(4):648-60.
Pecker LH, Naik RP. The current state of sickle cell trait: implications for reproductive and genetic counseling. Blood. 2018;132(22):2331-8.
de Montalembert M, Bonnet D, Lena-Russo D, Briard ML. Ethical aspects of neonatal screening for sickle cell disease in Western European countries. Acta Paediatr. 2005;94(5):528-30.
Peres MJ, Carreiro MH, Machado MC, Seixas T, Picanço I, Batalha L, et al. Rastreio neonatal de hemoglobinopatias numa população residente em Portugal [Neonatal screening of hemoglobinopathies in a population residing in Portugal]. Acta Med Port. 1996;9(4-6):135-9. Portuguese
Khangura SD, Potter BK, Davies C, Ducharme R, Bota AB, Hawken S, et al. Health services use by children identified as heterozygous hemoglobinopathy mutation carriers via newborn screening. BMC Pediatr. 2021;21(1):296.
Cober MP, Phelps SJ. Penicillin prophylaxis in children with sickle cell disease. J Pediatr Pharmacol Ther. 2010;15(3):152-9.
Ojodu J, Hulihan MM, Pope SN, Grant AM. Incidence of sickle cell trait - United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(49):1155-8.
Christopher SA, Collins JL, Farrell MH. Effort required to contact primary care providers after newborn screening identifies sickle cell trait. J Natl Med Assoc. 2012;104(11-12):528-34.
Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Experience with parent follow-up for communication outcomes after newborn screening identifies carrier status. J Pediatr. 2020;224:37-43.e2.
Lei nº 12/2005, de 26 de janeiro. Diário da República. Série I-A(18).
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
